Cincinnati Children’s Hospital Medical Center has rolled out a 14-month clinical trial for testing mobile technology in aiding the management of teenagers with asthma.
For the effort, the hospital has teamed with GenerationOne, a wireless health platform provider.
“Mobile phones represent an appealing technology for tailoring interventions and bridging knowledge to action in adolescents but there was limited knowledge in this area,” says Dr. Michael Seid, PhD, principal investigator and a professor in the Division of Pulmonary Medicine and the Anderson Center for Health Systems Excellence.
The program aims to:
- Examine the acceptability, for adolescents with moderate or severe asthma, of an intervention based on existing problem-solving and motivational interventions.
- Develop and beta-test a mobile-phone based platform for the intervention.
- Feasibility test and pilot test the intervention to determine short-term efficacy in adolescents with moderate or severe asthma.
The program acknowledged above “will serve as a basis for efforts to secure funding for a larger clinical trial to fully test the efficacy of this intervention,” Dr. Seid confesses.
All told, Cincinnati Children’s and GenerationOne developed and tested self-management interventions for adolescents with asthma that incorporate efficacious components that were tailored, via mobile technology, to adolescent needs. The goal was to develop and pilot test a personalized multimodal behavioral intervention incorporating motivation, knowledge, and problem-solving skills to overcome barriers to adherence in adolescents with moderate and severe persistent asthma.
“Asthma continues to impose a considerable health burden on the U.S. population, especially in adolescents. GenerationOne was pleased to tailor a mobile program for Cincinnati Children’s research program for testing teen’s ability to use mobile devices in helping them control Asthma in real life situations,” according to Jeff Wolf, Founder and CEO GenerationOne.